Literature DB >> 6491735

A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.

T Hoshino.   

Abstract

Cell kinetics studies of patients with various gliomas published in the past decade have shown that the average labeling index (LI) obtained from a pulse of 3H-thymidine is very high in medulloblastomas (12.0% +/- 1.3%, standard error of the mean) and glioblastoma multiforme (9.3% +/- 1.0%), low in well differentiated gliomas (less than 1%), and intermediate in anaplastic astrocytomas (4.0% +/- 0.8%). The higher the LI, the faster the tumor grows, probably reflecting a larger growth fraction. In tumor tissues obtained at autopsy, two glioblastomas diluted out the labeling compound in the 2- to 4-month interval after labeling, whereas three glioblastomas and two anaplastic astrocytomas retained labeled neoplastic cells for 3 weeks to 5 months. Most patients whose tumors contained foci of labeled cells at autopsy survived longer. Well differentiated gliomas harbored labeled cells for 2 1/2 to 7 years. These findings indicate that the kinetics of proliferation in well differentiated gliomas are different from those in glioblastomas or anaplastic astrocytomas.

Entities:  

Mesh:

Year:  1984        PMID: 6491735     DOI: 10.3171/jns.1984.61.5.0895

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  30 in total

Review 1.  The role of image-guided technology in the surgical planning and resection of gliomas.

Authors:  G H Barnett
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 2.  Stereotactic approach to intracranial lesions.

Authors:  G Lo Russo; C Munari; O O Betti; A Musolino; B Turak; T Hamasaki; R Rosle; D Hoffmann; A L Benabid
Journal:  Ital J Neurol Sci       Date:  1992-02

3.  A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.

Authors:  S Sharma; A K Karak; R Singh; V S Mehta; C Sarkar; H P Schmitt
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.

Authors:  M R Wacker; T Hoshino; D K Ahn; R L Davis; M D Prados
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Fetal origin of the medulloblastoma: evidence from growth analysis of two cases.

Authors:  K Hirakawa; K Suzuki; S Ueda; J Handa
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 6.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

7.  Recurrent low-grade glioma in children with special reference to computed tomography findings and pathological changes.

Authors:  N Morota; K Sakamoto; N Kobayashi; K Hashimoto
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

8.  The future role of neurosurgery in the care of cerebral tumors.

Authors:  K Sano
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

9.  The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

Authors:  R Schröder; K Bien; R Kott; I Meyers; R Vössing
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

Authors:  Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.